Netherlands vs United States: Coverage of the human papillomavirus vaccine
Netherlands
66
in 2025
United States
66
in 2025
Netherlands rank
48th
United States rank
48th
Coverage of the human papillomavirus vaccine over time
- Netherlands
- United States
How they compare
Netherlands currently reports 66 against 66 in United States, a difference of 0.
The two have swapped places 3 times across 14 shared years of data; in 2012 it was Netherlands ahead.
Netherlands ranks 48th and United States ranks 48th of 85 countries.
Across the 2 decades both report, Netherlands averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | Netherlands | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.38 | 47.62 | 8.75 | Netherlands |
| 2020s | 65.67 | 66.33 | 0.6667 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Netherlands or United States?
- Netherlands, at 66 against 66 in United States as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Netherlands and United States?
- 0, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and United States?
- 14 years are reported by both, from 2012 to 2025.
- How do Netherlands and United States rank globally for coverage of the human papillomavirus vaccine?
- Netherlands ranks 48th and United States ranks 48th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.